WASHINGTON, D.C. – The FDA’s latest guidance released over the weekend provided an accelerated path for high-complexity laboratories to support additional testing capacity in response to the COVID-19 outbreak. ... Read More
WASHINGTON, D.C. – ACLA is currently reviewing the FDA’s guidance for high complexity, CLIA-certified laboratories (which includes hospital, academic, and commercial laboratories) to provide coronavirus testing ... Read More
Commercial Labs Working Closely with Public Health Partners, Stand Ready To Support Increased Test Capacity If Needed WASHINGTON, D.C. — In response to the latest ... Read More
